arsenic has been researched along with cyclin d1 in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Kawakami, K; Kawamoto, K; Shi, C; Tsuchida, T; Zhao, S | 1 |
| Hee Cho, Y; Hyuck Im, Y; Hyun Park, W; Ki Kang, W; Kim, K; Lee, MH; Oh Park, J; Park, K; Won Jung, C | 1 |
| Achanzar, WE; Chen, H; Cheng, ML; Diwan, BA; Liu, J; Waalkes, MP; Xie, Y; Zhou, YS | 1 |
| Hayash, H; Horii, T; Kitamura, K; Kobayashi, M; Maekawa, M; Naito, K; Nakamura, S; Naoe, T; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A | 1 |
| Ding, RS; Jiang, SH; Lu, W; Xu, RR; Yuan, HJ | 1 |
| Ai, Z; Liu, H; Lu, W; Qin, X; Shen, Z; Sou, T; Ton, S | 1 |
| Andrew, AS; Duell, EJ; Mason, RA; Memoli, V | 1 |
| Tchounwou, PB; Yedjou, CG | 1 |
| Cox, AJ; Davis, BH; Davis, KT; Fang, G; Hock, JM; Li, X; Liu, Y; Sullivan, C | 1 |
| Chen, Z; Jung, HJ; McCarty, N | 1 |
| Kwong, YL; Lo, RK | 1 |
| Drzewucka, J; Gackowska, L; Gagat, M; Grzanka, A; Litwiniec, A; Zuryń, A | 1 |
| Duan, X; Gao, XH; Li, B; Li, J; Li, W; Sun, G; Xing, X; Zhang, Y; Zhao, L | 1 |
| Chang, SH; Hong, SC; Jeong, JH; Jung, JM; Kim, GS; Lee, WS; Lu, JN; Nagappan, A; Yun, JW | 1 |
| Chai, CY; Chang, SJ; Lan, CE; Lee, CH; Liao, WT; You, HL; Yu, CL; Yu, HS | 1 |
| Roszak, J; Smok-Pieniążek, A; Stępnik, M | 1 |
| An, Y; Deng, H; Li, C; Ni, Y; Wang, X; Zhu, Z | 1 |
| Chen, F; Fan, C; Gao, Y; Li, B; Liu, X; Lou, Q; Yang, Y; Yin, F; Zhang, M; Zhang, X; Zhang, Z | 1 |
| Han, B; Han, X; Li, C; Liu, R; Ma, Z; Xie, R; Yang, L; Yang, Q; Zhang, J | 1 |
1 trial(s) available for arsenic and cyclin d1
| Article | Year |
|---|---|
Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lymphoma, Mantle-Cell; Male; Oxides; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Retinoblastoma Protein; Transcription, Genetic; Ubiquitination | 2014 |
18 other study(ies) available for arsenic and cyclin d1
| Article | Year |
|---|---|
Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
Topics: Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Division; Cyclin B; Cyclin B1; Cyclin D1; Dose-Response Relationship, Drug; Flow Cytometry; Glioblastoma; Humans; Oxides; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Renal Cell; Caspases; CDC2-CDC28 Kinases; Cell Cycle; Cell Division; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Humans; Kidney Neoplasms; Oxides; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma Protein; Tumor Cells, Cultured | 2003 |
Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero.
Topics: Animals; Arsenicals; Aryl Hydrocarbon Hydroxylases; Carcinogens; Chemical and Drug Induced Liver Injury; Cyclin D1; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 7; DNA Methylation; Environmental Exposure; Estrogen Receptor alpha; Estrogens; Fetus; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Liver; Liver Diseases; Liver Neoplasms, Experimental; Male; Mice; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Steroid Hydroxylases | 2004 |
Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2004 |
[Apoptosis of in vitro cultured BMMNC from MDS patients induced by arsenic sulfide].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Arsenicals; bcl-2-Associated X Protein; Bone Marrow Cells; Cyclin D1; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Myelodysplastic Syndromes; RNA, Messenger; Sulfides | 2006 |
Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor.
Topics: Arsenic Trioxide; Arsenicals; Carcinoma; Cell Line, Tumor; Cyclin D1; Down-Regulation; Gallbladder Neoplasms; Humans; Oxides; Sp1 Transcription Factor; Transcription, Genetic; Transfection | 2007 |
Arsenic activates EGFR pathway signaling in the lung.
Topics: Adult; Aged; Amphiregulin; Analysis of Variance; Arsenic; Arsenites; Biomarkers; Bronchi; Cells, Cultured; Cyclin D1; Cycloheximide; EGF Family of Proteins; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Glycoproteins; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Lung; Lung Neoplasms; Middle Aged; Nails; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Compounds | 2009 |
Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide.
Topics: Arsenic Trioxide; Arsenicals; Cyclin A1; Cyclin D1; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Neoplasm Proteins; Oxides; Proto-Oncogene Proteins c-fos; Response Elements; Tubulin; Tumor Suppressor Protein p53 | 2009 |
Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low-dose arsenite-induced cell proliferation.
Topics: Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Flow Cytometry; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nuclear Proteins; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Stability; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2010 |
Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Drug Synergism; Humans; Lymphoma, Mantle-Cell; Oxides; Pyrazines | 2012 |
The influence of arsenic trioxide on the cell cycle, apoptosis and expression of cyclin D1 in the Jurkat cell line.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Death; Cell Line; Cyclin D1; Humans; Jurkat Cells; Microscopy, Electron, Transmission; Oxides | 2014 |
Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.
Topics: Antioxidants; Apoptosis; Arsenic; bcl-2-Associated X Protein; Catalase; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Cytoplasm; Heme Oxygenase-1; Humans; Hydroquinones; Keratinocytes; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase | 2016 |
Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Enzyme Activation; G2 Phase Cell Cycle Checkpoints; Humans; Membrane Potential, Mitochondrial; Oxides; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand; Time Factors | 2017 |
Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
Topics: Aged; Aneuploidy; Arsenic; Biopsy; Bowen's Disease; CpG Islands; Cyclin D1; Disease Progression; DNA Demethylation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Promoter Regions, Genetic; Skin Neoplasms | 2018 |
Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cyclin D1; Drug Resistance, Neoplasm; Forkhead Box Protein O1; Gene Expression Profiling; Genes, jun; HL-60 Cells; Humans; Oxides; Phosphatidylinositol 3-Kinases; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |
[Effect of low-dose exposure to sodium arsenite on proliferation of HBE and HaCaT cells].
Topics: Arsenic; Arsenites; Cell Cycle; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Epithelial Cells; Humans; Keratinocytes; Sodium Compounds; Up-Regulation | 2017 |
Malignant growth of arsenic-transformed cells depends on activated Akt induced by reactive oxygen species.
Topics: Arsenic; Cell Proliferation; Cyclin D1; Humans; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2023 |
[Rat serum containing oxymatrine inhibits the proliferation of LX2 human hepatic stellate cells induced by sodium arsenite via blocking PI3K/AKT pathway].
Topics: Alkaloids; Animals; Arsenic; Arsenites; bcl-2-Associated X Protein; Cell Proliferation; Cyclin D1; Hepatic Stellate Cells; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Quinolizines; Rats; Rats, Sprague-Dawley; Sodium Compounds | 2022 |